Propanc Biopharma Stock Price Prediction

PPCB Stock  USD 0.0003  0.00  0.00%   
At the present time, The relative strength index (RSI) of Propanc Biopharma's share price is at 53 indicating that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Propanc Biopharma, making its price go up or down.

Oversold Vs Overbought

53

 
Oversold
 
Overbought
The successful prediction of Propanc Biopharma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Propanc Biopharma, which may create opportunities for some arbitrage if properly timed.
Using Propanc Biopharma hype-based prediction, you can estimate the value of Propanc Biopharma from the perspective of Propanc Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Propanc Biopharma to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Propanc because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Propanc Biopharma after-hype prediction price

    
  USD 3.7E-4  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Propanc Biopharma Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Propanc Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.000.000314.58
Details

Propanc Biopharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Propanc Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Propanc Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Propanc Biopharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Propanc Biopharma Estimiated After-Hype Price Volatility

In the context of predicting Propanc Biopharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Propanc Biopharma's historical news coverage. Propanc Biopharma's after-hype downside and upside margins for the prediction period are 0.00 and 14.58, respectively. We have considered Propanc Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.0003
0.0004
After-hype Price
14.58
Upside
Propanc Biopharma is out of control at this time. Analysis and calculation of next after-hype price of Propanc Biopharma is based on 3 months time horizon.

Propanc Biopharma Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Propanc Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Propanc Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Propanc Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.05 
14.46
 0.00  
  0.01 
0 Events / Month
8 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.0003
0.0004
23.21 
0.00  
Notes

Propanc Biopharma Hype Timeline

Propanc Biopharma is at this time traded for 0.0003. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Propanc is forecasted to increase in value after the next headline, with the price projected to jump to 3.7E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is estimated to be 23.21%, whereas the daily expected return is at this time at -0.05%. The volatility of related hype on Propanc Biopharma is about 6337.05%, with the expected price after the next announcement by competition of 0.01. Propanc Biopharma currently holds 1.1 M in liabilities. Debt can assist Propanc Biopharma until it has trouble settling it off, either with new capital or with free cash flow. So, Propanc Biopharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Propanc Biopharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Propanc to invest in growth at high rates of return. When we think about Propanc Biopharma's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be within a week.
Check out Propanc Biopharma Basic Forecasting Models to cross-verify your projections.

Propanc Biopharma Related Hype Analysis

Having access to credible news sources related to Propanc Biopharma's direct competition is more important than ever and may enhance your ability to predict Propanc Biopharma's future price movements. Getting to know how Propanc Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Propanc Biopharma may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
OCEAOcean Biomedical 0.02 3 per month 0.00 (0.13) 7.46 (6.93) 28.33 
ENVBEnveric Biosciences 0.01 7 per month 0.00 (0.17) 6.25 (7.50) 28.33 
HEPAHepion Pharmaceuticals(0.02)4 per month 0.00 (0.03) 8.06 (8.11) 33.54 
ELEVElevation Oncology 0.01 10 per month 0.00 (0.10) 5.77 (8.22) 22.21 
AVROAVROBIO 0.05 5 per month 1.89  0.01  4.11 (3.17) 14.20 
CWBRCohBar Inc 0.07 3 per month 5.34  0.08  5.73 (5.59) 250.97 
ZURAZura Bio Limited(0.08)10 per month 0.00 (0.04) 8.08 (7.94) 30.69 
CVACCureVac NV 0.04 8 per month 0.00 (0.11) 4.45 (4.51) 16.27 
RETAReata Pharmaceuticals 0.37 6 per month 3.31  0.02  5.24 (3.51) 28.80 
KRYSKrystal Biotech 1.93 11 per month 0.00 (0.06) 4.45 (3.75) 12.05 
VIRVir Biotechnology 0.11 7 per month 0.00 (0.07) 4.49 (5.81) 35.87 

Propanc Biopharma Additional Predictive Modules

Most predictive techniques to examine Propanc price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Propanc using various technical indicators. When you analyze Propanc charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Propanc Biopharma Predictive Indicators

The successful prediction of Propanc Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Propanc Biopharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Propanc Biopharma based on analysis of Propanc Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Propanc Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Propanc Biopharma's related companies.

Story Coverage note for Propanc Biopharma

The number of cover stories for Propanc Biopharma depends on current market conditions and Propanc Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Propanc Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Propanc Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Propanc Biopharma Short Properties

Propanc Biopharma's future price predictability will typically decrease when Propanc Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Propanc Biopharma often depends not only on the future outlook of the potential Propanc Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Propanc Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding220.4 M

Complementary Tools for Propanc Pink Sheet analysis

When running Propanc Biopharma's price analysis, check to measure Propanc Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Propanc Biopharma is operating at the current time. Most of Propanc Biopharma's value examination focuses on studying past and present price action to predict the probability of Propanc Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Propanc Biopharma's price. Additionally, you may evaluate how the addition of Propanc Biopharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk